Bristol-Myers Squibb Co [BMY] attracts people because of its fundamentals

The stock of Bristol-Myers Squibb Co (NYSE:BMY) last traded at $55.83, up 0.07% from the previous session. BMY stock price is now -2.18% away from the 50-day moving average and 10.25% away from the 200-day moving average. The market capitalization of the company currently stands at $113.30B. With the price target maintained at $70, Jefferies […]

An overview of Bristol-Myers Squibb Co’s (BMY) institutional holdings

The price of Bristol-Myers Squibb Co (NYSE:BMY) shares last traded on Wall Street fell -0.32% to $58.95. BMY stock price is now 2.22% away from the 50-day moving average and 18.06% away from the 200-day moving average. The market capitalization of the company currently stands at $119.56B. With the price target maintained at $70, Jefferies […]

Does Bristol-Myers Squibb Co (NYSE:BMY) have deteriorating prospects?

Bristol-Myers Squibb Co (NYSE:BMY) shares traded 0.90% higher at $59.67 on Wall Street last session. BMY stock price is now 3.64% away from the 50-day moving average and 20.09% away from the 200-day moving average. The market capitalization of the company currently stands at $121.02B. With the price target maintained at $70, Jefferies recently Upgraded […]

A secret that hides Bristol-Myers Squibb Co’s strength (NYSE:BMY)

Stocks of Bristol-Myers Squibb Co (NYSE:BMY) traded higher last session on Wall Street, down -1.73% to $55.83. BMY stock price is now -2.29% away from the 50-day moving average and 12.82% away from the 200-day moving average. The market capitalization of the company currently stands at $113.23B. With the price target maintained at $70, Jefferies […]

Is Bristol-Myers Squibb Co (NYSE:BMY) being unfairly punished by investors?

In yesterday’s Wall Street session, Bristol-Myers Squibb Co (NYSE:BMY) shares traded at $57.68, down -0.55% from the previous session. BMY stock price is now 2.04% away from the 50-day moving average and 16.99% away from the 200-day moving average. The market capitalization of the company currently stands at $116.34B. With the price target maintained at […]